Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00764504 · ClinicalTrials.gov registry record · Phase 3
Reverse Shoulder Prosthesis Study
A Phase 3 study, sponsored by Encore Medical, L.P..
- Completed
- Registry status
- Phase 3
- Development phase
- 516
- Enrollment target
NCT00764504: Completed Phase 3 study, sponsored by Encore Medical, L.P..
NCT00764504 is a Phase 3 study that has completed, run by Encore Medical, L.P.. The registered enrollment target is 516 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (33% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00764504, a Phase 3 study, has completed, sponsored by Encore Medical, L.P..
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 516 participants
- Enrollment target
Study Summary
The objective of this clinical study is to evaluate the safety and efficacy of the Encore Reverse Shoulder Prosthesis (RSP). The clinical results of the RSP will be compared to clinical results published in literature for rotator cuff arthropathy and salvage procedures.
Primary Outcome
The patient self-report section of the ASES is a condition specific scale which is intended to measure functional limitations and pain of the shoulder. On a scale of 0 to 100, the use of their shoulder is measured with 0 = no use and 100 = full use. The assessment is done in two sections. One Pain (measured by the Visual Analog Pain Scale) and the second is a list of 10 questions referred to as the Activities of Daily Living. The results are calculated with the following equation: \[(10 - Visua
Interventions
- DEVICE Reverse Shoulder Prosthesis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 516 participants |
| Start Date | 2002-10 |
| Est. Completion | 2008-08 |
| Phase | Phase 3 |
What the finished NCT00764504 record still lists
NCT00764504 is an interventional study that assigns participants to a tested intervention. The registered 516 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (33% lower).
The record links to 0 conditions, and to 1 intervention - of which Reverse Shoulder Prosthesis is the first listed.
NCT00764504 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00764504 about?
NCT00764504 is a clinical study titled "Reverse Shoulder Prosthesis Study". The objective of this clinical study is to evaluate the safety and efficacy of the Encore Reverse Shoulder Prosthesis (RSP). The clinical results of the RSP will be compared to clinical results published in literature for rotator cuff arthropathy and salvage procedures.
What is the current status of trial NCT00764504?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 516 participants. The study started on 2002-10. Estimated completion is 2008-08.
What interventions are being tested in trial NCT00764504?
The interventions under investigation include: Reverse Shoulder Prosthesis (DEVICE).
Who is sponsoring clinical trial NCT00764504?
This trial is sponsored by Encore Medical, L.P., which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00764504's enrollment target sits among peer trials
516 724th of 2000 higher than 1,277 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05933083 · 516 participants · NA
MCNAIR Study: coMparative effeCtiveness of iN-person and teleheAlth cardIac Rehabilitation
- NCT05676450 · 517 participants · NA
Feasibility and Clinical Utility of Cell-free DNA (cfDNA) in Identifying Actionable Alterations and Minimal Residual Disease for Lymphoma Patients Across Community Centers in Texas
- NCT05577819 · 515 participants · NA
Prevalence and Prediction of ATTR in Ambulatory Patients With HFpEF
- NCT06804837 · 515 participants · NA
Implement and Test Visual Consent Template and Process
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia